Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
The American Journal of Medicine|January 4, 2014
Anaphylaxis: a payor's perspective on epinephrine autoinjectorsJeffrey D Dunn, David A Sclar
Pharmacoeconomics|November 26, 2013
Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequencesJeffrey F Barletta, David A Sclar
Pharmacoeconomics|October 13, 2010
Economic implications of sleep disordersTracy L Skaer, David A Sclar
Critical Care (London, England)|December 26, 2014
Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patientsJeffrey F Barletta, David A Sclar
The Journal of Clinical Psychiatry|September 7, 2012
Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failureLawrence J Cohen, David A Sclar
Primary Care Companion to the Journal of Clinical Psychiatry|August 10, 2010
Hospital admission for schizophrenia and discharge against medical advice in the United StatesDavid A Sclar, Linda M Robison
The American Journal of Medicine|January 4, 2014
Anaphylaxis: underdiagnosed, underreported, and undertreatedDavid A Sclar, Phillip L Lieberman
The Journal of Clinical Psychiatry|February 20, 2013
MAOIs: issues in treatment adherence and rates of treatment failureLawrence J Cohen, David A Sclar
The American Journal of Managed Care|July 19, 2011
Economic considerations for the treatment of opioid and alcohol dependence: a managed care perspectiveJeffrey D Dunn
The American Journal of Managed Care|September 3, 2010
Diabetes pharmacy management: balancing safety, cost, and outcomesJeffrey D Dunn
Pageof 8